4/A//SEC Filing
HAFKIN BARRY MD 4/A
Accession 0001209191-05-005341
CIK 0001161924other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 3:58 PM ET
Size
5.9 KB
Accession
0001209191-05-005341
Insider Transaction Report
Form 4/AAmended
HAFKIN BARRY MD
SVP, Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2005-01-24+65,000→ 65,000 totalExercise: $4.05Exp: 2015-01-23→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]2.083% of the Options vest and become exercisable each month, commencing one month after February 15, 2005 (the "Initial Vesting Date") and on such day of every month thereafter, through the fourth anniversary of the Initial Vesting Date.
Documents
Issuer
ADVANCIS PHARMACEUTICAL CORP
CIK 0001161924
Entity typeother
Related Parties
1- filerCIK 0001285148
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 3:58 PM ET
- Size
- 5.9 KB